Literature DB >> 15470285

Elevation of C-reactive protein in people with prehypertension.

Dana E King1, Brent M Egan, Arch G Mainous, Mark E Geesey.   

Abstract

The objective of this study was to determine the relationship of C-reactive protein (CRP) and blood pressure (BP) across the range of BP categories including prehypertension. The Third National Health and Nutrition Examination Survey (NHANES III) data collected from 1988 to 1994 were analyzed. In unadjusted analyses, there was a step-wise increase in the probability of elevated CRP across a wide range of BP categories. Prehypertensive participants had a higher prevalence of elevated CRP than normotensive people (27.4% vs. 19.8%; p<05). After adjustment for age, gender, race, smoking, body mass index, exercise, diabetes, and medication usage, participants with systolic BP 120-139 mm Hg or diastolic BP 80-89 mm Hg were more likely to have elevated CRP than people with systolic BP <120 (odds ratio, 1.36; 95% confidence interval, 1.14-1.62; odds ratio, 1.20; 95% confidence interval, 1.02-1.41, respectively). CRP and BP are positively related across a wide range of BP categories. A substantial proportion of prehypertensive individuals have elevated CRP independent of multiple confounders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15470285      PMCID: PMC8109659          DOI: 10.1111/j.1524-6175.2004.03577.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  31 in total

1.  Body mass index, diabetes, and C-reactive protein among U.S. adults.

Authors:  E S Ford
Journal:  Diabetes Care       Date:  1999-12       Impact factor: 19.112

2.  Inflammatory markers and exercise: differences related to exercise type.

Authors:  Dana E King; Peter Carek; Arch G Mainous; William S Pearson
Journal:  Med Sci Sports Exerc       Date:  2003-04       Impact factor: 5.411

3.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.

Authors:  P M Ridker; M J Stampfer; N Rifai
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

4.  Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects.

Authors:  R P Tracy; B M Psaty; E Macy; E G Bovill; M Cushman; E S Cornell; L H Kuller
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

5.  Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs.

Authors:  V Pasceri; J S Cheng; J T Willerson; E T Yeh; J Chang
Journal:  Circulation       Date:  2001-05-29       Impact factor: 29.690

6.  Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Tiejian Wu; Joan P Dorn; Richard P Donahue; Christopher T Sempos; Maurizio Trevisan
Journal:  Am J Epidemiol       Date:  2002-01-01       Impact factor: 4.897

7.  The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration.

Authors:  M H Wener; P R Daum; G M McQuillan
Journal:  J Rheumatol       Date:  2000-10       Impact factor: 4.666

8.  C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.

Authors:  Dilys J Freeman; John Norrie; Muriel J Caslake; Allan Gaw; Ian Ford; Gordon D O Lowe; Denis St J O'Reilly; Chris J Packard; Naveed Sattar
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

9.  C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

Authors:  Sridevi Devaraj; Dan Yan Xu; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

10.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  25 in total

Review 1.  Hypertension as an autoimmune and inflammatory disease.

Authors:  Yalcin Solak; Baris Afsar; Nosratola D Vaziri; Gamze Aslan; Can Ege Yalcin; Adrian Covic; Mehmet Kanbay
Journal:  Hypertens Res       Date:  2016-04-07       Impact factor: 3.872

2.  Race, genes and preterm delivery.

Authors:  Kevin Fiscella
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

3.  Early inflammatory and metabolic changes in association with AGTR1 polymorphisms in prehypertensive subjects.

Authors:  Maple M Fung; Fangwen Rao; Sameer Poddar; Manjula Mahata; Srikrishna Khandrika; Sushil K Mahata; Daniel T O'Connor
Journal:  Am J Hypertens       Date:  2010-09-23       Impact factor: 2.689

Review 4.  Role of hypertension in the metabolic syndrome: who is affected?

Authors:  Gladys Velarde; Bradford C Berk
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

5.  Use of statins and blood pressure.

Authors:  Dana E King; Arch G Mainous; Brent M Egan; Marty Player; Mark E Geesey
Journal:  Am J Hypertens       Date:  2007-09       Impact factor: 2.689

Review 6.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

7.  All in the family: The link between kin network bridging and cardiovascular risk among older adults.

Authors:  Alyssa W Goldman
Journal:  Soc Sci Med       Date:  2016-07-28       Impact factor: 4.634

8.  Elevated blood pressure, race/ethnicity, and C-reactive protein levels in children and adolescents.

Authors:  Marc B Lande; Thomas A Pearson; Roger P Vermilion; Peggy Auinger; Isabel D Fernandez
Journal:  Pediatrics       Date:  2008-12       Impact factor: 7.124

9.  Carotid artery stiffness, high-density lipoprotein cholesterol and inflammation in men with pre-hypertension.

Authors:  K S Heffernan; R H Karas; J T Kuvin; S Y Jae; V J Vieira; B Fernhall
Journal:  J Hum Hypertens       Date:  2009-02-19       Impact factor: 3.012

10.  hs-CRP: A potential marker for hypertension in Kashmiri population.

Authors:  M Shafi Dar; A A Pandith; A S Sameer; M Sultan; A Yousuf; Syed Mudassar
Journal:  Indian J Clin Biochem       Date:  2010-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.